Durham-based Oxygen Biotherapeutics executes reverse 1-for-15 stock split
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
DURHAM, N.C. – Shares in Oxygen Biotherapeutics (OTC Bulletin Board: OXBO) will be trading sharply higher Monday after the company completed a reverse 1-for-15 stock split on Friday after the markets closed.
Shares traded at 41 cents Friday.
The share symbol also changes Monday to OXBT.
"This reverse split was overwhelmingly approved by our shareholders in support of our plan to move the listing of our shares to a major exchange from the over-the-counter bulletin board," said Chris Stern, Oxyben’s chief executive officer, in a statement. "We believe that moving the listing will enhance the liquidity of our shares and improve our ability to attract new investors as we move ahead with our product development plans.”
We have filed the application to move our listing and will be working to facilitate and execute the listing move as fast as the stock exchange will allow us to do it.”
Shareholders approved the stock move on Oct. 19.
The number of shares will be reduced to some 19.6 million from nearly 294 million.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
The Skinny
- Charlotte's startup efforts pick up steam as more data pours in
- 'Battle in Bay 7' returns - Are you techies ready for some basketball?
- Inside RTP's new angel fund: Founders meeting 'significant' need
- Who won 'Social Bowl'? Super Bowl ads paying fans to play
- RTP broadband firm Overture, minus two top execs, launches new look
- Will RTP-based ChannelAdvisor go public? They're thinking
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised
- Erskine Bowles is among those who can cash in big time on Facebook IPO


